Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports.
Färnert
Anna
A
Department of Medicine, Division of Infectious Diseases, Karolinska Institute, Karolinska Hospital, S-171 76 Stockholm, Sweden. anna.farnert@medks.ki.se
Lindberg
Johan
J
Gil
Pedro
P
Swedberg
Göte
G
Berqvist
Yngve
Y
Thapar
Mita M
MM
Lindegårdh
Niklas
N
Berezcky
Sándor
S
Björkman
A
A
D000962:Antimalarials / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D053626:Atovaquone; D002675:Child, Preschool; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007223:Infant; D016778:Malaria, Falciparum / Q000188:drug therapy*; D008297:Male; D009285:Naphthoquinones / Q000627:therapeutic use*; D002727:Proguanil / Q000627:therapeutic use*; D013607:Tablets
D000962:Antimalarials; D000981:Antiprotozoal Agents; D009285:Naphthoquinones; D013607:Tablets; D002727:Proguanil; D053626:Atovaquone